About Christian Angermayer
Christian Angermayer is a director and 10% owner at Enhanced Group.
Form D filings name Christian Angermayer as a chairman, co-founder, board director at Cambrian Bio.
Christian Angermayer reports to the SEC as a director, officer or major shareholder of 8 public companies, including AtaiBeckley (ATAI), Enhanced (ENHA) and Atai Beckley N.V. (ATAI).
Christian Angermayer first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Christian Angermayer in the role, so the role may have started earlier or lasted longer.
EI
Enhanced Group Inc.
Director and 10% owner
2026 · Public company (ENHA)
AI
AtaiBeckley Inc.
Director and 10% owner
2026 · Public company (ATAI)
EL
Enhanced Ltd
Director and 10% owner
2026 · Public company (ENHA)
AV
Atai Beckley N.V.
Director and 10% owner
2021 – 2025 · Public company (ATAI)
Cambrian BioPharma Inc
Chairman, Co-Founder, Board Director
2021 – 2025 · New York, NY
Develops medicines targeting metabolic decline and related chronic diseases.
BA
Bionomics Ltd/adr
10% owner
2024 · Public company (BNOX)
AI
FI
Faeth Therapeutics, Inc.
10% owner
2022 – 2023 · Public company (FTH)
FC
Frontier Acquisition Corp.
Chief Executive Officer and director
2021 · Public company (FRONU)
Key Colleagues at Startups
The people Christian Angermayer works with at each company, as listed on that company's latest Form D.
Cambrian BioPharma Inc · Form D/A, Jan 13, 2025
Maryanna Saenko
Board Director
-modified.png)
Paul Farr
Board Director
James Peyer
CEO, Founder, Board Director
-modified.png)
Brenton Saunders
Board Director